Brunner Hr
Impact in
-
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
- Heart Failure Treatment and Management
- Heart Rate Variability and Autonomic Control
-
- Hormonal Regulation and Hypertension
Papers in
-
- Blood Pressure and Hypertension Studies 7
- Heart Failure Treatment and Management 5
-
- Protein Hydrolysis and Bioactive Peptides 6
- Co-authors
- Michel Burnier (8 shared papers)Bernard Waeber (33 shared papers)B. Waeber (14 shared papers)J. Nussberger (20 shared papers)Haralambos Gavras (11 shared papers)Laragh Jh (2 shared papers)Jérôme Biollaz (7 shared papers)D. B. Brunner (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (5 papers)Journal of Cardiovascular Pharmacology (1 paper)International Journal of Clinical Practice (1 paper)The Lancet (1 paper)PubMed (67 papers)
- Partner nations
- SwitzerlandFranceGermany
In The Last Decade
Brunner Hr
71 papers receiving 1.1k citations
Brunner Hr's Hit Papers
Peers
Comparison fields: 5 of 98
- Cardiology and Cardiovascular Medicine 761
- Endocrinology, Diabetes and Metabolism 363
- Family Practice 39
- Geriatrics and Gerontology 33
- Nephrology 56
Countries citing papers authored by Brunner Hr
This map shows the geographic impact of Brunner Hr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brunner Hr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brunner Hr more than expected).
Fields of papers citing papers by Brunner Hr
This network shows the impact of papers produced by Brunner Hr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brunner Hr. The network helps show where Brunner Hr may publish in the future.
Co-authors
The 25 scholars most cited alongside Brunner Hr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Angiotensin II receptor antagonists Hit paper breakdown → | 2000 | 566 |
| 2 | 1981 | 105 | |
| 3 | Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics. | 1973 | 54 |
| 4 | 1999 | 41 | |
| 5 | Plasma angiotensins under sustained converting enzyme inhibition with enalapril in normal humans. | 1985 | 23 |
| 6 | Comparative antihypertensive effects of angiotensin II receptor antagonists. | 1999 | 23 |
| 7 | 1981 | 19 | |
| 8 | Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. | 1981 | 19 |
| 9 | Clinical pharmacology of atrial natriuretic (3-28) eicosahexapeptide. | 1986 | 18 |
| 10 | 1985 | 18 | |
| 11 | Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats. | 1987 | 14 |
| 12 | [Superficial pemphigus caused by captopril]. | 1982 | 14 |
| 13 | 2004 | 14 | |
| 14 | What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition. | 1988 | 11 |
| 15 | Physiologic studies with saralasin in animals. | 1979 | 10 |
| 16 | [Inhibition of plasmatic renin activity by potassium]. | 1967 | 10 |
| 17 | Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance. | 1976 | 9 |
| 18 | Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers. | 1996 | 9 |
| 19 | Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers. | 1987 | 8 |
| 20 | Experience with perindopril in normal volunteers. | 1989 | 8 |
About Brunner Hr
Brunner Hr is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Nutrition and Dietetics, Pediatrics, Perinatology and Child Health and Endocrinology, Diabetes and Metabolism, having authored 75 papers that have together received 1.2k indexed citations. Recurring topics across this work include Vitamin K Research Studies (10 papers), Blood Pressure and Hypertension Studies (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Protein Hydrolysis and Bioactive Peptides (6 papers), Hormonal Regulation and Hypertension (6 papers), Heart Failure Treatment and Management (5 papers), Pharmaceutical studies and practices (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (761 citations), Endocrinology, Diabetes and Metabolism (363 citations), Family Practice (39 citations), Geriatrics and Gerontology (33 citations) and Nephrology (56 citations). Brunner Hr has collaborated with scholars based in Switzerland, France and Germany. Frequent co-authors include Michel Burnier, Bernard Waeber, B. Waeber, J. Nussberger, Haralambos Gavras, Laragh Jh, Jérôme Biollaz, D. B. Brunner, Ulrich Keller and W Vetter. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Cardiovascular Pharmacology, International Journal of Clinical Practice, The Lancet and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.